Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.22 USD -0.85%
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Interest Income Expense Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Interest Income Expense
$27.8m
CAGR 3-Years
N/A
CAGR 5-Years
110%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Interest Income Expense
$570k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Interest Income Expense
ÂŁ12.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Interest Income Expense
-$29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Interest Income Expense
-ÂŁ344k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Interest Income Expense
-ÂŁ200k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
24%

See Also

What is Bicycle Therapeutics PLC's Interest Income Expense?
Interest Income Expense
27.8m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Interest Income Expense amounts to 27.8m USD.

What is Bicycle Therapeutics PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
110%

Over the last year, the Interest Income Expense growth was 337%.

Back to Top